RxTeach

Sign in Subscribe

OASIS-4 Journal Club

Clinical Pharmacy

OASIS-4 Journal Club

Journal club review of the OASIS-4 trial evaluating oral semaglutide 25 mg for weight loss, including efficacy, safety outcomes, and clinical impact.

The Importance of a Value Proposition

Pharmacy Industry

The Importance of a Value Proposition

Why great drugs fail without a story: how pharma value propositions turn clinical data into stakeholder-specific impact and market access.

Hypervolemic Hyponatremia

Clinical Pharmacy

Hypervolemic Hyponatremia

Hyponatremia in hypervolemic patients explained: risks in older adults, safe sodium correction, and treatment options including loop diuretics and vaptans.

Health Literacy Is a Public Health Emergency in the South: What Student Pharmacists Can Do Now

Health Literacy Is a Public Health Emergency in the South: What Student Pharmacists Can Do Now

Start early. Start now. Start for the reason you chose this profession, to improve patients’ health and change lives through understanding.

Progress Isn't Perfect

Health and Wellness

Progress Isn't Perfect

Perseverance is the most important factor in achieving any goal, despite the setbacks or less-than-ideal weeks.

The Andexxa Paradox

Clinical Pharmacy

The Andexxa Paradox

Andexxa withdrawn after ANNEXA-I showed higher stroke risk; clinicians return to 4F-PCC for DOAC reversal while new agents emerge.

December Recap 2025

Paid-members only

December Recap 2025

We are back with another monthly post for our paid subscribers. In this post, we also share a number of fun things that are more personal, interesting, and meant to create a closer community around RxTeach.

Kaplan-Meier Curves in Oncology

Kaplan-Meier Curves in Oncology

Introduction Kaplan-Meier (KM) survival curves are foundational to oncology clinical trials and can be central to how efficacy is assessed for cytotoxic chemotherapy, targeted therapies, immunotherapies, and cellular therapies. Endpoints such as overall survival (OS), progression-free survival (PFS), event-free survival (EFS), and duration of response (DoR) are almost universally presented

The Best Bodyweight Exercises

Health and Wellness

The Best Bodyweight Exercises

We're covering the best exercises that require no weights, can be done almost anywhere, and will get you guaranteed results when done correctly!

How VO2 Max Training Extends Your Life

Health and Wellness

How VO2 Max Training Extends Your Life

Like your GPA, fitness is easier to maintain than it is to build, particularly as you get older. Your VO2 max will decrease over time, no matter what you do. The key is to get it as high as you can now and then hold on to it for as long as you can.

What is Zone 2 Training?

Health and Wellness

What is Zone 2 Training?

We know cardiovascular training, especially in Zone 2, enhances your metabolic and mitochondrial flexibility, so please don't ignore it! Your life may depend on it, and your quality of life definitely does.

Guide for Aerobic vs Anaerobic Exercise Regimens

Health and Wellness

Guide for Aerobic vs Anaerobic Exercise Regimens

The association between aerobic or anaerobic activity and health benefits has been studied for many decades and continues to enhance our understanding of the importance of physical activity and exercise.

Benefits of Aerobic and Anaerobic Exercise

Health and Wellness

Benefits of Aerobic and Anaerobic Exercise

Lack of physical activity among Americans is linked to about $117 billion in annual healthcare costs as well as about 10% of premature mortality.

How to Lose Weight in 2026

Health and Wellness

How to Lose Weight in 2026

This article will walk you through the nutrition and exercise principles required to lose weight most effectively without drug use.

ACLS Pharmacotherapy Review: Part 1

Clinical Pharmacy

ACLS Pharmacotherapy Review: Part 1

Orphan Drugs and Their Market Implications

Pharmacy Industry

Orphan Drugs and Their Market Implications

Orphan drugs drive innovation in rare disease treatment through incentives and exclusivity, enhancing care while raising concerns about pricing, access, and policy implications.

Comparison and Competition

Health and Wellness

Comparison and Competition

The absolute most important takeaway should be this: whatever you’re striving for, make sure it’s something you genuinely care about, not just a goal that others expect of you or think you should pursue

November Recap 2025

Paid-members only

November Recap 2025

We are back with another monthly post for our paid subscribers. In this post, we also share a number of fun things that are more personal, interesting, and meant to create a closer community around RxTeach.

DOTS Journal Club

DOTS Journal Club

New JAMA DOTS study (2025) finds dalbavancin as a potential IV-therapy alternative with results similar to standard therapy for S. aureus bacteremia

2026 GOLD Report Updates

Clinical Pharmacy

2026 GOLD Report Updates

Discover what’s new in the 2026 GOLD COPD Report including earlier detection, new risk definitions, treatment updates, and emerging tech shaping patient care.

Circulating Tumor DNA: Overview and Application

Circulating Tumor DNA: Overview and Application

Circulating tumor DNA has emerged as one of the most powerful biomarkers in modern oncology, enabling non-invasive, real-time assessment of tumor biology.

Health Care Disparities in Palliative Care

Health and Wellness

Health Care Disparities in Palliative Care

This article looks at how unconscious bias and health disparities limit palliative care access, with strategies to improve equity and support better patient outcomes.

Careers Pathways in Drug Discovery: From Bench to Commercialization

Pharmacy Industry

Careers Pathways in Drug Discovery: From Bench to Commercialization

Drug development moves from discovery to clinical trials and real-world use, driven by collaboration between scientists and healthcare workers too

Let's Talk Daptomycin

Clinical Pharmacy

Let's Talk Daptomycin

DeLLphi-304 Journal Club

Clinical Pharmacy

DeLLphi-304 Journal Club

Compared to chemotherapy, tarlatamab showcased improved efficacy and safety following progression on or after platinum-based therapies.